Pharma Pulse 1/30/25: Treating Disruptive Symptom’s in Crohn’s Patients, Majority of Americans Support Medicare and Medicaid & more

News
Article

The latest news for pharma industry insiders.

Treating Disruptive Symptom’s in Crohn’s Patients

The European Medicines Agency’s Committee for Medicinal Products for Human Use recently issued a positive opinion for the use of Omvoh for the treatment of moderate to severe Crohn’s in adults. Mark Genovese, MD, senior vice president at Lilly Immunology Development, spoke with Pharmaceutical Executive about the importance of developing medicines that treat disruptive symptoms of chronic conditions.

Majority of Americans Support Medicare and Medicaid Amid Federal Spending Cut Talks

As the nation is again under the reigns of a Trump administration and a Republican-led Congress, debates on reducing spending have not affected the public’s feelings on these programs.

Trump Renews Universal Tariff Threat to ‘Protect Our Country’

President Trump wants to impose across-the-board tariffs that are "much bigger" than 2.5% to reshape US supply chains and protect American workers and businesses. Trump threatened tariffs on specific sectors, including semiconductors, pharmaceuticals, steel, copper, and aluminum, and suggested imposing them on automobiles from Canada and Mexico. Trump's tariff plan aims to add costs to imports and lower taxes on domestic production, with the goal of bringing manufacturing back to the US and creating jobs. Robb Watters, Managing Partner at The Madison Group discusses on Balance of Power. (Source: Bloomberg)

New Poll: Majority of Americans Support Keeping Vaccines Widely Available to Protect Children and Communities

The Partnership to Fight Infectious Disease released results of a public opinion poll that reveals most American voters, regardless of political affiliation, support the continued availability of FDA-approved vaccines and express concern over declining childhood vaccination rates.

Pharmaceutical Executive on LinkedIn

Calling all rising stars in pharma and biotech! The 2025 Emerging Pharma Leaders Awards are here to celebrate the next generation of trailblazers shaping the future of our industry.

Nominate yourself or someone you admire who embodies leadership, innovation, and vision. Are they c-suite bound? Do they inspire others while navigating the complexities of R&D, marketing, sales, or market access?

This is your chance to spotlight the leaders of tomorrow. Submit your nomination today: https://ow.ly/4qgm50UOZ4e

#PharmaLeaders #EmergingLeaders #PharmaInnovation

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs

© 2025 MJH Life Sciences

All rights reserved.